{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:22Z","timestamp":1791596962266,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101137033"],"award-info":[{"award-number":["101137033"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PICREID"],"award-info":[{"award-number":["PICREID"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI137276"],"award-info":[{"award-number":["R01 AI137276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI175134"],"award-info":[{"award-number":["R01 AI175134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01AI151758"],"award-info":[{"award-number":["1U01AI151758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["311543\/Z\/24\/Z"],"award-info":[{"award-number":["311543\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.116128","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:25:20Z","timestamp":1788629120000},"page":"116128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic chikungunya is associated with decreased anti-CHIKV antibody titers, neutralizing capacity, and antibody-dependent cellular cytotoxicity"],"prefix":"10.1016","volume":"29","author":[{"given":"Vinit","family":"Upasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokchea","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sievleang","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvino","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreymom","family":"Ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopheak","family":"Sorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithea","family":"Leang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowath","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veasna","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tineke","family":"Cantaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116128_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/fmb.12.139","article-title":"Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease","volume":"8","author":"Coffey","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.isci.2026.116128_bib2","article-title":"Global emergence of Alphaviruses that cause arthritis in humans","volume":"5","author":"Wesula Olivia","year":"2015","journal-title":"Infect. Ecol. Epidemiol."},{"key":"10.1016\/j.isci.2026.116128_bib3","article-title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus","volume":"172","author":"Pezzi","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.116128_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay004","article-title":"Chikungunya is back in Italy: 2007-2017","volume":"25","author":"Rezza","year":"2018","journal-title":"J. Travel Med."},{"key":"10.1016\/j.isci.2026.116128_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208896","article-title":"Local transmission of chikungunya in Rome and the Lazio region, Italy","volume":"13","author":"Vairo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116128_bib6","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1473-3099(20)30491-6","article-title":"Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses","volume":"21","author":"Zaid","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: Evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.116128_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijid.2023.12.004","article-title":"Climate change and the rising incidence of vector-borne diseases globally","volume":"139","author":"George","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib9","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/v11020175","article-title":"Tropism of the Chikungunya Virus","volume":"11","author":"Matusali","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.116128_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","article-title":"Chikungunya fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.116128_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/qjmed\/hcae028","article-title":"Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives","volume":"117","author":"Ng","year":"2024","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.isci.2026.116128_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901610010129","article-title":"A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis","volume":"10","author":"Goupil","year":"2016","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.isci.2026.116128_bib14","first-page":"23","article-title":"Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy. New Microbe","volume":"7","author":"Pierro","year":"2015","journal-title":"New Infect."},{"key":"10.1016\/j.isci.2026.116128_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171989","article-title":"The neutralizing role of IgM during early Chikungunya virus infection","volume":"12","author":"Chua","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116128_bib16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/517537","article-title":"Outbreak of chikungunya on Reunion Island: Early clinical and laboratory features in 157 adult patients","volume":"44","author":"Borgherini","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2334-9-200","article-title":"Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies","volume":"9","author":"Malvy","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib18","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0855-2020","article-title":"Long-Term Persistence of Serum-Specific Anti-Chikungunya IgM Antibody - A Case Series of Brazilian Patients","volume":"54","author":"Costa","year":"2021","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.isci.2026.116128_bib19","first-page":"142","article-title":"Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection","volume":"140","author":"Chaaithanya","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.isci.2026.116128_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12985-025-02721-x","article-title":"Long-term persistence of serum IgM antibodies against chikungunya virus in patients with chronic arthralgia","volume":"22","author":"Jacob-Nascimento","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.isci.2026.116128_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13337-019-00534-5","article-title":"Persistence of antibody response in chikungunya","volume":"30","author":"Chelluboina","year":"2019","journal-title":"Virusdisease"},{"key":"10.1016\/j.isci.2026.116128_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3201\/eid2502.180166","article-title":"Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil","volume":"25","author":"Bozza","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-11-183","article-title":"Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand","volume":"11","author":"Nitatpattana","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.isci.2026.116128_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.116128_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chom.2015.06.009","article-title":"Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus","volume":"18","author":"Smith","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.116128_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003684","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"9","author":"Weber","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005318","article-title":"Identification of Functional Determinants in the Chikungunya Virus E2 Protein","volume":"11","author":"Weber","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004163","article-title":"Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses","volume":"9","author":"Weger-Lucarelli","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib29","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.celrep.2015.11.043","article-title":"Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis","volume":"13","author":"Jin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116128_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clim.2013.10.004","article-title":"Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model","volume":"149","author":"Goh","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.116128_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.116128_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92750","article-title":"Fc functional antibodies in humans with severe H7N9 and seasonal influenza","volume":"2","author":"Vanderven","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.116128_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116128_bib35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116128_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.817905","article-title":"Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort","volume":"13","author":"Vo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib38","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.cell.2022.11.012","article-title":"Antibody effector functions are associated with protection from respiratory syncytial virus","volume":"185","author":"Bartsch","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116128_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cei\/uxad101","article-title":"Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults","volume":"214","author":"Lakerveld","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116128_bib41","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","article-title":"Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice","volume":"8","author":"Yamin","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.116128_bib42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.abc7303","article-title":"Antibody fucosylation predicts disease severity in secondary dengue infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116128_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116128_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116128_bib46","doi-asserted-by":"crossref","first-page":"eabm7853","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116128_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav5062","article-title":"Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-Fc\u03b3R interaction on monocytes","volume":"4","author":"Fox","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1153108","article-title":"Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using Fc\u03b3RIIIa affinity chromatography","volume":"14","author":"Fox","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib49","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.4049\/jimmunol.172.12.7694","article-title":"Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes","volume":"172","author":"Wipke","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib50","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.4049\/jimmunol.0900153","article-title":"The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease","volume":"183","author":"Wenink","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107527","article-title":"Serum concentration of antigen-specific IgG can substantially bias interpretation of antibody-dependent phagocytosis assay readout","volume":"26","author":"St Germain","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.116128_bib53","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41467-023-40960-0","article-title":"SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations","volume":"14","author":"Hederman","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116128_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0045-2016","article-title":"The Role and Function of Fc\u03b3 Receptors on Myeloid Cells","volume":"4","author":"Bournazos","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.116128_bib55","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.4049\/jimmunol.1900985","article-title":"Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity","volume":"203","author":"Temming","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib56","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.179.5.2815","article-title":"Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen","volume":"179","author":"Tang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4049\/jimmunol.1700116","article-title":"Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fc\u03b3 Receptor Profile","volume":"199","author":"Bruggeman","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib58","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1111\/febs.16073","article-title":"Natural killer cell effector functions in antiviral defense","volume":"289","author":"Piersma","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2026.116128_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s41598-018-36972-2","article-title":"NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation\/IFN-\u03b3 Production Suppress Antibody-dependent Enhancement of Dengue Viral Infection","volume":"9","author":"Sun","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116128_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007084","article-title":"Risk Factors for Hospitalization of Patients with Chikungunya Virus Infection at Sentinel Hospitals in Puerto Rico","volume":"13","author":"Hsu","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051519","article-title":"Impact of Chikungunya on Health Related Quality of Life Chennai, South India","volume":"7","author":"Ramachandran","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116128_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008281","article-title":"Chikungunya outbreak (2015) in the Colombian Caribbean: Latent Classes and Gender Differences in Virus Infection","volume":"14","author":"Vidal","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib63","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/v14081805","article-title":"Serological and Clinical Analysis of Chikungunya Virus Infection in Thai Patients","volume":"14","author":"Tun","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.116128_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41541-023-00722-x","article-title":"Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need","volume":"8","author":"Cherian","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.116128_bib65","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116128_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Richardson","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116128_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102332","article-title":"Persistent germinal center responses: slow-growing trees bear the best fruits","volume":"83","author":"Matz","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2026.116128_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176537","article-title":"Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO","volume":"9","author":"Lucas","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.116128_bib69","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.celrep.2016.06.076","article-title":"Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence","volume":"16","author":"Hawman","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116128_bib70","doi-asserted-by":"crossref","first-page":"e1008292","DOI":"10.1371\/journal.ppat.1008292","article-title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2","volume":"16","author":"McCarthy","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.116128_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcv.2019.06.001","article-title":"Characterization of antibody response in patients with acute and chronic chikungunya virus disease","volume":"117","author":"Anfasa","year":"2019","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.isci.2026.116128_bib72","doi-asserted-by":"crossref","first-page":"e0278-2023","DOI":"10.1590\/0037-8682-0278-2023","article-title":"Inflammation, fibrosis and E1 glycoprotein persistence in joint tissue of patients with post-chikungunya chronic articular disease","volume":"56","author":"Brito","year":"2023","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.isci.2026.116128_bib73","article-title":"Chikungunya virus persists in joint-associated macrophages and promotes chronic disease","author":"Zarrella","year":"2025","journal-title":"Res. Sq."},{"key":"10.1016\/j.isci.2026.116128_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007993","article-title":"Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA","volume":"15","author":"Young","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.116128_bib75","article-title":"Rewiring PBMC responses to prevent CHIKV infection-specific monocyte subset redistribution and cytokine responses","author":"Alberto Aguilar-Brise\u00f1o","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.116128_bib76","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20177862","article-title":"Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases","volume":"14","author":"Michlmayr","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2026.116128_bib77","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4269\/ajtmh.20-1398","article-title":"Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection","volume":"104","author":"Patil","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2026.116128_bib78","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection Apr 1","volume":"205","author":"Kam","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib79","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3201\/eid1812.120471","article-title":"Reemergence of Chikungunya Virus in Cambodia","volume":"18","author":"Duong","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-017-0010-0","article-title":"Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community","volume":"7","author":"Auerswald","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.isci.2026.116128_bib81","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(24)00357-8","article-title":"Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study","volume":"24","author":"McMahon","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.116128_bib82","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2023.05.032","article-title":"A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice","volume":"41","author":"Rao","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.116128_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128251","article-title":"Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya","volume":"75","author":"Kling","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.116128_bib84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7861\/clinmed.2019-0035","article-title":"Chikungunya arthritis","volume":"19","author":"Pathak","year":"2019","journal-title":"Clin. Med."},{"key":"10.1016\/j.isci.2026.116128_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/trstmh\/try063","article-title":"Chikungunya chronic disease: a systematic review and meta-analysis","volume":"112","author":"Paix\u00e3o","year":"2018","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2026.116128_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172358","article-title":"Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes","volume":"12","author":"Jean","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116128_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijmm.2008.08.002","article-title":"Broad-range real-time PCR assay for the rapid identification of cell-line contaminants and clinically important mollicute species","volume":"299","author":"St\u00f6rmer","year":"2009","journal-title":"Int. J. Med. Microbiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226015038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226015038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:54:15Z","timestamp":1791593655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226015038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226015038"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116128","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic chikungunya is associated with decreased anti-CHIKV antibody titers, neutralizing capacity, and antibody-dependent cellular cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116128"}}